As IL-10 and TGF-beta expressing T cells are known to play a crucial role for inducing Foxp3+ T regulatory cells and controlling immune responses in NSCLC (31, 35), these results suggest that IL-9 plays an important role in regulating immune responses in lung cancer in vivo. This evidence concerns the gene IL9 and lung carcinoma.